Results 31 to 40 of about 5,497,042 (305)

A new pea variety ‘Skif’

open access: yesЗерновое хозяйство России, 2022
The wide distribution of peas among leguminous crops relates to its diverse use. Grain is used for food and feed; green mass is an excellent high-protein animal feed.
A. R. Ashiev   +2 more
doaj   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

Stability and Adaptability of Early-Medium Maturing Maize Varieties

open access: yesAgronomy
Field experiments were conducted at 23 sites in Poland during the 2021–2023 growing seasons to evaluate the interaction between genotypes and environments on grain yield and plant height in 15 maize varieties with medium-early maturity.
Karolina Piecuch   +4 more
doaj   +1 more source

Breeding of the facultative barley varieties at the FSBSI ARC «Donskoy»

open access: yesЗерновое хозяйство России, 2023
The current paper is devoted to the study of promising barley lines with an alternative type of development (facultative). Famous breeders P. F. Garkavy and V. M.
A. A. Dontsova   +2 more
doaj   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Barley Varieties Registered in the Czech Republic after Harvest 2017

open access: yesKvasný průmysl, 2018
Spring barley malting varieties Accordine, KWS Fantex, LG Nabuco, Pilote, and Spitfire and winter barley variety KWS Donau were registered after harvest 2017. The spring barley varieties were rich in extract. The varieties Spitfire, LG Nabuco, Accordine,
Vratislav Psota   +3 more
doaj   +1 more source

Barley varieties registered in the Slovak Republic after the harvest of 2021

open access: yesKvasný průmysl, 2022
After three years of testing, the spring barley varieties Amidala, Ellinor and LG Belcanto were registered in the Slovak Republic. Extract of the varieties was between 82.3 and 82.8 %.
Vratislav Psota   +3 more
doaj   +1 more source

Barley Variety Test

open access: yes, 2002
Sixteen varieties were included in the 2005 barley test at Nashua. Each variety was sown in three different plots to average the effects of soil variability. The varieties were planted on March 29 at a rate of 2 bushels/acre. All barley plots were harvested on July 28.
Skrdla, Ronald, Jannink, Jean-Luc
openaire   +11 more sources

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy